Oncogene expression in prostate cancer
β Scribed by M. J. G. Bussemakers; J. T. Isaacs; F. M. J. Debruyne; W. J. M. Ven; J. A. Schalken
- Book ID
- 104654531
- Publisher
- Springer-Verlag
- Year
- 1991
- Tongue
- English
- Weight
- 990 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0724-4983
No coin nor oath required. For personal study only.
β¦ Synopsis
An important molecular approach for the Subline Histology Growth-rate Androgen Metatstatic doubling time responsive ability b (days) H Well-differentiated 22 --5 Yes Low HIS Well-differentiated 24 --5 No Low HIM Well-differentiated 9 ___ 0.8 No Low HIF Moderately differentiated 4.8 --1.8 No Low G Poorly differentiated 4 --0.2 Yes Low M A T L u Anaplastic 2.7 --0.2 No High (lungs) c AT-1 Anaplastic 2.5 +_ 0.2 No Low AT-2 Anaplastic 2.5 ___ 0.2 No Low to moderate (lungs) AT-3 Anaplastic 1.8 + 0.2 No High (lymph nodes, lungs) MATLyLu Anaplastic 1.5 +_ 0.1 No High (lymph nodes, lungs)
π SIMILAR VOLUMES
## Abstract Both amplification and overexpression of cβ__erb__ Bβ2/__neu__ have been associated with the progression and possible prognosis of a number of human cancers. In this study, we demonstrated that cβ__erb__ Bβ2/__neu__ may also play an important role in human prostate cancer. Our conclusio